Trends and disparities in the use of cholinesterase inhibitors to treat Alzheimer’s disease dispensed by the Brazilian public health system – 2008 to 2014: a nation-wide analysis
ABSTRACT In light of the high cost of dementia treatment, there is legislation authorizing free distribution of cholinesterase inhibitors to those suffering from Alzheimer’s disease in Brazil. However, the existence of this free distribution does not guarantee adequate distribution. Objectives The...
Saved in:
| Main Authors: | Flávia Silva de Moraes, Mariana Lima Cerqueira de Souza, Giancarlo Lucchetti, Alessandra Lamas Granero Lucchetti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000700444&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of Antipsychotic Initiation Among Older Dementia Patients Initiating Cholinesterase Inhibitors
by: Chikermane SG, et al.
Published: (2025-03-01) -
Comparison of cholinesterase inhibitor safety in real‐world practice
by: Greg Carney, et al.
Published: (2019-01-01) -
Revisiting capsaicin and nonivamide: Their analogs exert strong inhibitory activity against cholinesterases
by: Niels V. Heise, et al.
Published: (2024-12-01) -
Evaluation of cholinesterase level in workers exposed to organophosphates
by: A Barkhordri, et al.
Published: (2012-10-01) -
Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer’s Treatment: Systematic Review
by: Maryam N. ALNasser, et al.
Published: (2025-02-01)